Concomitant boost radiotherapy for muscle invasive bladder cancer

Radiotherapy and Oncology

Volumn 68, Issue 1, 2003, Pages 75-80

  Pos, Floris J ^a   Van Tienhoven, Geertjan ^a   Hulshof, Maarten C C M ^a   Koedooder, Kees ^a   González González, Dionisio ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Accelerated fractionation; Bladder cancer; Partial bladder boost; Radical radiotherapy

Indexed keywords

ACUTE TOXICITY; ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER TOXICITY; BOWEL TOXICITY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER REGRESSION; CARDIOVASCULAR DISEASE; CHRONIC TOXICITY; CLINICAL ARTICLE; CYSTITIS; DIARRHEA; DYSURIA; FEMALE; HUMAN; ILEUS; MALE; MUSCLE METASTASIS; PRIORITY JOURNAL; RADIATION DOSE; REGRESSION ANALYSIS; SCORING SYSTEM; TRANSITIONAL CELL CARCINOMA;

EID: 0142043347     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(03)00019-7     Document Type: Article

References (26)

1. Battermann J.J., Tierie A.H. Results of implantation for T1 and T2 bladder tumours. Radiother Oncol. 5:1986;85-90.
2. Cole D.J., Durrant K.R., Roberts J.T., Dawes P.J., Yosef H., Hopewell J.W. A pilot study of accelerated fractionation in the radiotherapy of invasive carcinoma of the bladder. Br J Radiol. 65:1992;792-798.
3. Davidson S.E., Symonds R.P., Snee M.P., Upadhyay S., Habeshaw T., Robertson A.G. Assessment of factors influencing the outcome of radiotherapy for bladder cancer. Br J Urol. 66:1990;288-293.
4. Fish J.C., Fayos J.V. Carcinoma of the urinary bladder. Influence of dose and volume irradiated on survival. Radiology. 118:1976;179-182.
5. Fowler J.F. How worthwhile are short schedules in radiotherapy? A series of exploratory calculations. Radiother Oncol. 18:1990;165-181.
6. Fowler J.F., Harari P.M. Confirmation of improved local-regional control with altered fractionation in head and neck cancer. Int J Radiat Oncol Biol Phys. 48:2000;3-6.
7. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 48:2000;7-16.
8. González González D., van der Veen H.J., Ypma A.F., Blank L.E., Hoestra C.J., Veen R.E. Brachytherapy for urinary bladder cancer. Arch Esp Urol. 52:1999;655-661.
9. ICRU Report 50. Prescribing, recording and reporting photon beam therapy: International Commission on Radiation Units and Measurement: Bethesda, MD: 1993.
10. Kaplan E.L., Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
11. Langen K.M., Jones D.T. Organ motion and its management. Int J Radiat Oncol Biol Phys. 50:2001;265-278.
12. Maciejewski B., Majewski S. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiother Oncol. 21:1991;163-170.
13. Marks L.B., Carroll P.R., Dugan T.C., Anscher M.S. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 31:1995;1257-1280.
14. Miralbell R., Nouet P., Rouzaud M., Bardina A., Hejira N., Schneider D. Radiotherapy of bladder cancer: relevance of bladder volume changes in planning boost treatment. Int J Radiat Oncol Biol Phys. 41:1998;741-746.
15. Moonen L.M., Horenblas S., van der Voet J.C., Nuyten M.J., Bartelink H. Bladder conservation in selected T1G3 and muscle-invasive T2-T3a bladder carcinoma using combination therapy of surgery and iridium-192 implantation. Br J Urol. 74:1994;322-327.
16. Moonen L.M., Horenblas S., Pos F., Schaefer B.S., Meinhardt W., Bartelink H. Good results of bladder-preserving treatment in poorly differentiated and invasive bladder carcinoma using interstitial Iridium-192 radiotherapy. Ned Tijdschr Geneeskd. 140:1996;1406-1410.
17. Moonen L., van der Voet H., Horenblas S., Bartelink H. A feasibility study of accelerated fractionation in radiotherapy of carcinoma of the urinary bladder. Int J Radiat Oncol Biol Phys. 37:1997;537-542.
18. Moonen L., v.d. Voet H., de Nijs R., Hart A.A., Horenblas S., Bartelink H. Muscle-invasive bladder cancer treated with external beam radiotherapy: pretreatment prognostic factors and the predictive value of cystoscopic re-evaluation during treatment. Radiother Oncol. 49:1998;149-155.
19. Plataniotis G., Michalopoulos E., Kouvaris J., Vlahos L., Papavasiliou C. A feasibility study of partially accelerated radiotherapy for invasive bladder cancer. Radiother Oncol. 33:1994;84-87.
20. Pos FJ, Koedooder K, Hulshof MCCM, van Tienhoven G, González González D. Influence of bladder and rectal volume on spatial variability of a bladder tumor during radical radiotherapy. Int J Radiat Oncol Biol Phys 2003;55:835-41.
21. Quilty P.M., Duncan W., Kerr G.R. Results of a randomised study to evaluate influence of dose on morbidity in radiotherapy for bladder cancer. Clin Radiol. 36:1985;615-618.
22. Scholten A.N., Leer J.W., Collins C.D., Wondergem J., Hermans J., Timothy A. Hypofractionated radiotherapy for invasive bladder cancer. Radiother Oncol. 43:1997;163-169.
23. Sengelov L., von der Maase H. Radiotherapy in bladder cancer. Radiother Oncol. 52:1999;1-14.
24. Turner SL, Swindell R, Bowl N, et al. Bladder movement during radiation therapy for bladder cancer: implications for treatment planning. Int J Radiat Oncol Biol Phys 1997;39:355-360.
25. nd Revision, 1992.
26. Wilson G.D., McNally N.J., Dische S., Bennett M.H. Cell proliferation in human tumours measured by in-vivo labeling with bromodeoxyuridine. Br J Radiol. 61:1988;419-422.